Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generics, Not Reimportation, Are Solution To High Drug Costs – McClellan

Executive Summary

States should encourage more generic drug use - not reimportation - as a way to lower pharmacy costs, FDA Commissioner McClellan said

You may also be interested in...



Importation Debate Highlights Need For Lower Rx Prices, McClellan Says

The debate over drug importation highlights the need for reduced drug prices, Centers for Medicare & Medicaid Services Administrator Mark McClellan said Aug. 30

Importation Debate Highlights Need For Lower Rx Prices, McClellan Says

The debate over drug importation highlights the need for reduced drug prices, Centers for Medicare & Medicaid Services Administrator Mark McClellan said Aug. 30

Drug Importation Would Undermine Waxman/Hatch, Generic Industry Says

A legalized system of drug importation would undermine Waxman/Hatch incentives for generic drug development, the Generic Pharmaceutical Association told the HHS importation task force April 5

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel